About 330,000 results
BioAge stock rallies 29% following upsized $198M IPO
BioAge Labs Announces Pricing of Upsized Initial Public Offering
BioAge Labs IPO: stock price today in high-profile Nasdaq debut
BioAge valued at $758 million in debut as investors bet on
BioAge posts double-digit percentage jump after IPO; natural-gas ...
Weight-loss drug developer BioAge raises $198 million in U.S. IPO …
BioAge posts double-digit percentage gain after IPO; natural-gas ...
BioAge Labs stock soars in weight loss drug maker's IPO - Quartz
BioAge Labs, A New Obesity Treatment Name, Rockets On Upsized IPO …
Obesity drug developer BioAge raises $198m in IPO
- Some results have been removed